Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Purinergic receptor P2X, ligand-gated ion channel, 7 pseudogene (commonly abbreviated as P2RX7 pseudogene, P2RX7P) is a non-functional genetic element in the human genome similar in sequence to the functional P2X7 receptor gene (P2RX7), but it does not encode an active receptor protein. It does not produce a product with ion channel or signaling activity, has no direct biological or pathophysiological function, is not a drug target, and is not associated with disease roles. Its presence is relevant primarily for genomic annotation, rather than for biomedical research or clinical targeting[2].
Not applicable; pseudogenes have no protein product or known mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic receptor P2X, ligand-gated ion channel, 7 pseudogene (P2RX7P).